REFRACTORY OVARIAN CARCINOMA
Clinical trials for REFRACTORY OVARIAN CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY OVARIAN CARCINOMA trials appear
Sign up with your email to follow new studies for REFRACTORY OVARIAN CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial offers hope for ovarian cancer that stopped responding to standard chemo
Disease control Recruiting nowThis study is testing an experimental drug called CBX-12 for women whose ovarian cancer has stopped responding to platinum-based chemotherapy. It aims to see if the drug is safe and can shrink tumors. About 40 participants will receive one of two different doses every three weeks…
Matched conditions: REFRACTORY OVARIAN CARCINOMA
Phase: PHASE2 • Sponsor: Cybrexa Therapeutics • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New hope: using a Patient's own supercharged cells to battle aggressive ovarian cancer
Disease control Recruiting nowThis early-stage study is testing a new personalized treatment for ovarian cancer that has returned or stopped responding to standard therapies. Doctors take a patient's own immune cells, grow and train them in a lab to recognize cancer, and then infuse them back into the patient…
Matched conditions: REFRACTORY OVARIAN CARCINOMA
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC